Double-biguanide therapy for resistant acanthamoeba keratitis.
about
Contact Lens-related Complications: A Review.Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba.Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.
P2860
Double-biguanide therapy for resistant acanthamoeba keratitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Double-biguanide therapy for resistant acanthamoeba keratitis.
@en
Double-biguanide therapy for resistant acanthamoeba keratitis.
@nl
type
label
Double-biguanide therapy for resistant acanthamoeba keratitis.
@en
Double-biguanide therapy for resistant acanthamoeba keratitis.
@nl
prefLabel
Double-biguanide therapy for resistant acanthamoeba keratitis.
@en
Double-biguanide therapy for resistant acanthamoeba keratitis.
@nl
P2860
P356
P1476
Double-biguanide therapy for resistant acanthamoeba keratitis
@en
P2093
Paolo Rama
Stanislav Matuska
P2860
P304
P356
10.1159/000334270
P577
2011-09-01T00:00:00Z